Page last updated: 2024-11-05

thiotepa and Agranulocytosis

thiotepa has been researched along with Agranulocytosis in 6 studies

Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).

Agranulocytosis: A decrease in the number of GRANULOCYTES; (BASOPHILS; EOSINOPHILS; and NEUTROPHILS).

Research Excerpts

ExcerptRelevanceReference
"Thirty-five patients with advanced gynecologic malignancies were entered into a phase I study evaluating thio-TEPA in combination with cisplatin (50 mg/m2) intravenously every 4 weeks."1.28Phase I evaluation of thio-TEPA in combination with cisplatin for advanced gynecologic malignancies. ( Edwards, CL; Freedman, RS; Kavanagh, J; Raber, MN; Sandles, LG; Scott, WR; Wharton, JT, 1990)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19903 (50.00)18.7374
1990's3 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
MAUER, AM1
KRILL, CE1
Hara, J1
Osugi, Y1
Ohta, H1
Matsuda, Y1
Nakanishi, K1
Takai, K1
Fujisaki, H1
Tokimasa, S1
Fukuzawa, M1
Okada, A1
Okada, S1
Langer, CJ1
Nash, S1
Catalano, R1
Rosenblum, NG1
Hogan, WM1
Comis, RL1
O'Dwyer, PJ1
Sandles, LG1
Freedman, RS1
Raber, MN1
Kavanagh, J1
Edwards, CL1
Scott, WR1
Wharton, JT1
Vagina, OG1
Vasiliev, AK1
Kirko, EI1
Veshler, VM1
Tarasenko, OP1

Trials

1 trial available for thiotepa and Agranulocytosis

ArticleYear
Phase II trial of thio-TEPA in relapsed and refractory ovarian carcinoma.
    Gynecologic oncology, 1991, Volume: 43, Issue:3

    Topics: Adenocarcinoma; Adult; Aged; Agranulocytosis; Carcinoma, Squamous Cell; Drug Evaluation; Female; Hum

1991

Other Studies

5 other studies available for thiotepa and Agranulocytosis

ArticleYear
A STUDY OF THE MECHANISMS OF GRANULOCYTOPENIA.
    Annals of the New York Academy of Sciences, 1964, Feb-28, Volume: 113

    Topics: Agranulocytosis; Anemia; Anemia, Macrocytic; Carcinoma; Carcinoma, Bronchogenic; Child; Hodgkin Dise

1964
Double-conditioning regimens consisting of thiotepa, melphalan and busulfan with stem cell rescue for the treatment of pediatric solid tumors.
    Bone marrow transplantation, 1998, Volume: 22, Issue:1

    Topics: Adolescent; Adult; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Child;

1998
Phase I evaluation of thio-TEPA in combination with cisplatin for advanced gynecologic malignancies.
    Gynecologic oncology, 1990, Volume: 39, Issue:2

    Topics: Agranulocytosis; Anemia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Evaluation;

1990
[A case of agranulocytosis following use of thio-TEPA].
    Pediatriia akusherstvo i ginekologiia, 1972, Volume: 5

    Topics: Adenocarcinoma; Agranulocytosis; Female; Humans; Middle Aged; Thiotepa; Uterine Neoplasms

1972
[Agranulocytic reaction associated with thio-tepa therapy].
    Klinicheskaia meditsina, 1971, Volume: 49, Issue:5

    Topics: Agranulocytosis; Humans; Thiotepa

1971